Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Class A common stock | Purchase | $5.85K | +450 | $13.00* | 450 | Nov 15, 2021 | Held by spouse | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | VAXX | Stock option (right to buy) | Award | $0 | +233K | $0.00 | 233K | Nov 11, 2021 | Class A common stock | 233K | $13.00 | Direct | F3 |
Id | Content |
---|---|
F1 | These securities were purchased through the Issuer's directed share program in connection with its initial public offering. |
F2 | These securities are held by Kathrin Palm, the Reporting Person's spouse. The Reporting Person disclaims beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the securities held by Kathrin Palm in which the Reporting Person has no pecuniary interest. |
F3 | These options are subject to a four-year time-vesting schedule, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal installments each month during the remainder of the vesting period. |